Related Experiment Video
Updated: Jan 9, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.7K
Identifying putative causal links between serum circulating microRNAs and thyroid cancer using Mendelian
1Zhejiang Sian International Hospital, Jiaxing, 314000, Zhejiang, China. gzy8042011@163.com.
Discover Oncology
|December 8, 2025
Summary
This study used Mendelian randomization to find causal links between specific microRNAs (miRNAs) and thyroid cancer risk. Certain miRNAs show harmful or protective effects, suggesting potential biomarkers for early diagnosis.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Thyroid cancer incidence is rising globally.
- Understanding risk factors is crucial for early detection and prevention.
- Serum circulating microRNAs (miRNAs) are potential novel biomarkers.
Purpose of the Study:
- To investigate the causal relationship between serum circulating miRNAs and thyroid cancer risk.
- To identify specific miRNAs associated with increased or decreased thyroid cancer susceptibility.
- To explore the underlying biological pathways involved.
Main Methods:
- Two-sample Mendelian randomization (MR) analysis.
- Utilized miRNA expression quantitative trait loci (eQTL) and thyroid cancer genome-wide association study (GWAS) data.
- Applied inverse variance-weighted (IVW) and MR-Egger methods; performed target gene and pathway analysis.
Main Results:
- Identified three miRNAs significantly associated with thyroid cancer risk: miR-hsa-125b-5p and miR-hsa-30a-3p (harmful), and miR-hsa-130a-3p (protective).
- Findings were consistent across discovery and validation cohorts.
- Enrichment analysis revealed involvement in gland development, cell senescence, and signaling pathways (FoxO, p53).
Conclusions:
- Specific serum miRNAs show potential causal associations with thyroid cancer risk.
- miR-hsa-125b-5p, miR-hsa-30a-3p, and miR-hsa-130a-3p warrant further investigation.
- These miRNAs could serve as potential biomarkers for thyroid cancer risk prediction and early diagnosis.
Related Concept Videos
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K

